University of Washington/Seattle Children's Hospital
Pediatric Pulmonology
Dr. Lucas Hoffman, MD
|
|
Give Review
Lucas Hoffman is an expert in the field of Pediatric Pulmonology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care He has 2 awards "Regional Top Doctor" and "Fellow (FAAP)". Doctor Lucas Hoffman, MD is a published doctor and has 39 publications published. The lastest was: 'Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion ac...'
Publications
- Narrowing in on early Cystic fibrosis lung disease.
- Strength in diversity.
- Directly sampling the lung of a young child with Cystic fibrosis reveals diverse microbiota.
- Pseudomonas aeruginosa in vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes.
- Pseudomonas aeruginosa Phenotypes Associated with Eradication Failure in Children with Cystic Fibrosis.
- Pediatric Infection and Intestinal Carriage due to Extended Spectrum Cephalosporin-Resistant Enterobacteriaceae.
- Gastrointestinal Pathology in Juvenile and Adult CFTR-Knockout Ferrets.
- Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with Cystic fibrosis.
- Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with Cystic fibrosis.
- The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research.
- Cystic fibrosis therapeutics: the road ahead.
- Emerging drugs for Bronchiectasis.
- Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult Cystic fibrosis lung show stability and res...
- Does bacterial density in cystic fibrosis sputum increase prior to Pulmonary exacerbation?
- Failure to recover to baseline Pulmonary function after cystic fibrosis Pulmonary exacerbation.
- Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from Cystic fibrosis patients.
- Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division.
- Comparing the microbiota of the Cystic fibrosis lung and human gut.
- Return of FEV1 after Pulmonary exacerbation in children with cystic fibrosis.
- Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.
- Did bacterial sensing of host environments evolve from sensing within microbial communities?
- Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa.
- The systems biology of infection in animal models bears fruit.
- Genetic adaptation by Pseudomonas aeruginosa to the airways of Cystic fibrosis patients.
- Lipoid Pneumonia due to Mexican folk remedies: cultural barriers to diagnosis.
- Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the Influenza hemagglutinin impair or abolish membrane fusion ac...
- Structure-based identification of an inducer of the low-pH conformational change in the Influenza virus hemagglutinin: irreversible inhibition of infectivity.
- The discovery, characterization and crystallographically determined binding mode of an FMOC-containing inhibitor of HIV-1 protease.
- Virus-cell and cell-cell fusion.
- Structure of N,N-[bis(2-pyridylmethyl)-gamma-aminobutyrato]copper(II) bromide methanol solvate.
- Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection.
- Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
- Using bacterial biomarkers to identify early indicators of cystic fibrosis Pulmonary exacerbation onset.
- Aminoglycoside antibiotics induce bacterial biofilm formation.
- Management of children with Empyema: Pleural drainage is not always necessary.
- Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with Cystic fibrosis.
- Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of Cystic fibrosis patients.
- Pseudomonas aeruginosa lasR mutants are associated with Cystic fibrosis lung disease progression.
Schools
University of California At San Francisco
Chldns Hospital
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Acidosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FAAP)
Education
-
University of Washington -
University of California San Francisco School of Medicine
Hospital
-
Seattle Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Susan G. Marshall, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bonnie Ramsey, MD |
|
|
Dr. Yemiserach Kifle, MD |
|
|
Dr. Maida L. Chen, MD |
|
|
Dr. Stephen R. Reeves, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Redding, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amanda M. Striegl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret Rosenfeld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Debley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Wilfond, MD
This Doctor is OpenDoctor Recommended.
|